Skip to search formSkip to main contentSkip to account menu

HSR-903

Known as: HSR 903 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

olamufloxacin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Distribution characteristics of orally administered olamufloxacin, a newly synthesized fluoroquinolone antibacterial, in lung epithelial lining fluid and alveolar macrophage in rats.
2003
2003
In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp.
The activity of the fluoroquinolone olamufloxacin (HSR-903) against Legionella spp. was studied in vitro and in vivo. The… 
2001
2001
The in vivo activity of olamufloxacin (HSR-903) in systemic and urinary tract infections in mice.
The in vivo activity of olamufloxacin (HSR-903), a new fluoroquinolone, was evaluated and compared with ciprofloxacin… 
1999
1999
Efflux transport of a new quinolone antibacterial agent, HSR-903, across the blood-brain barrier.
The distribution of HSR-903, a new quinolone antibacterial agent, to the brain after i.v. administration to rats was low compared… 
1999
1999
Carrier-mediated lung distribution of HSR-903, a new quinolone antibacterial agent.
HSR-903 [(S)-(-)-5-amino-7-(7-amino-5-azaspiro[2. 4]hept-5-yl)-1-cyclopropyl-6-fluoro-1, 4-dihydro-8-methyl-4-oxoquinoline-3… 
1999
1999
Tissue selective drug delivery utilizing carrier-mediated transport systems.
1999
1999
Effect of HSR-903, a New Fluoroquinolone, on the Concentration of Theophylline in Serum
ABSTRACT The effect of HSR-903, a new fluoroquinolone, on the concentration of theophylline in serum in healthy male volunteers… 
1998
1998
Hepatobiliary transport kinetics of HSR-903, a new quinolone antibacterial agent.
HSR-903 is a newly synthesized quinolone antibacterial agent with low toxicity. The biliary and urinary excretion of unchanged… 
1998
1998
In Vivo Activity of HSR-903, a New Fluoroquinolone, against Respiratory Pathogens
ABSTRACT The in vivo activity of HSR-903, a new fluoroquinolone, against major bacteria which cause respiratory tract infections… 
1997
1997
In-vitro antimicrobial activity of HSR-903, a new fluoroquinolone, against clinical isolates of Neisseria gonorrhoeae with quinolone resistance-associated alterations in GyrA and ParC.
The in-vitro antimicrobial activity of HSR-903, a new fluoroquinolone, was tested against 51 clinical Neisseria gonorrhoeae… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)